Dr. Anne Harasta

o Conducting and coordinating experimental studies using rodent models of human Alzheimer’s disease, frontotemporal dementia and epilepsy. o Coordinating projects that employ state-of-the-art neuropharmacogenetic techniques to drive therapeutic strategies using gene therapy. o Contribute to the preparation of journal manuscripts and conference presentations.

o Worked in a cross-functional team and analyzed novel therapeutic strategies for the treatment of rare genetic disorders that affect the central nervous system. o Employed state-of-the-art neuropharmacogenetic techniques to drive therapeutic strategies using gene therapy. o Generated standard operating procedures, risk assessments for equipment and laboratory protocols as well as corresponding ethic applications.

o Coordinated and evaluated relevant training of students and staff, ensured that relevant training meets WHS requirements and was completed within required timeframes. 
 o Liaised regularly with company representatives, academics and technical coordinators to facilitate high quality research. o Demonstrated time management and organizational skills within a team relevant to the management of a significant scientific research workforce

o Planned and executed weekly practical labs as well as tutoring sessions o Educated 100+ high school and primary school students from various schools from all over Sydney about the central as well as the peripheral nervous system as part of the ‘Brain Awareness Week”. o Involved in marking weekly spot tests for the 2nd year Physiology practical course and contributed to the short answer exam questions

o Studied the preclinical effects of an approved diabetes type II medication in the context of drug addiction. o Identified key components of neurological circuitries responsible to mediate drug-induced behavior, linking homeostatic pathways with drug abuse.

o Responsible for the set up of key laboratory methods and techniques to establish a state-of-the-art biomedical PC2 research laboratory. o Contributed to the development of viral vector-mediated gene therapies for neurological disorders of the central nervous system and exploring novel therapeutic strategies for the treatment of rare genetic disorders that affect the central nervous system.

o Utilized various biochemical as well as molecular biology techniques to identify second messenger signalling pathways of the endocannabinoid system. o General Laboratory Management

Neuroscience

Auslandsstudium (ERASMUS) Schwerpunkte: Molecular Biology, Developmental Biology, Human Anatomy

Physiologische Chemie, Zoology, Molecular Genetic